(Q43815296)

27 November 2017

title

Clinical experience with topiramate dosing and serum levels in children 12 years or under with epilepsy (English)

1 reference

27 November 2017

M J Schwabe

1

1 reference

27 November 2017

J W Wheless

series ordinal

2

1 reference

27 November 2017

publication date

1 November 2001

1 reference

Journal of Child Neurology

27 November 2017

published in

1 reference

27 November 2017

volume

16

1 reference

27 November 2017

issue

11

1 reference

27 November 2017

page(s)

806-808

1 reference

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F08830738010160110501

Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738010160110501

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738010160110501

Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738010160110501

A pilot study of topiramate in the treatment of infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738010160110501

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738010160110501

10.1177/08830738010160110501

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference